期刊
JOURNAL OF CARDIOLOGY
卷 69, 期 3-4, 页码 529-535出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jjcc.2016.04.011
关键词
Remnant lipoproteins; Diabetes mellitus; Chronic kidney disease; Prognosis; Cardiovascular events
资金
- JSPS KAKENHI [B2-19390209, B-22390158]
- Grants-in-Aid for Scientific Research [26461059] Funding Source: KAKEN
Background: Patients having type 2 diabetes mellitus (DM) and chronic kidney disease (CKD) are at high risk of cardiovascular events. Triglyceride-rich lipoprotein levels are synergistically increased in patients with DM and CKD. This study examined the predictive value of remnant lipoprotein levels for cardiovascular events in patients with DM and CKD. Methods: Three hundred and sixty-five patients with type 2 DM and CKD were enrolled. Serum levels of remnant lipoproteins (remnant-like lipoprotein particles cholesterol; RLP-C) were measured by an immunoseparation method. All patients were followed prospectively for a period of 45 23 months or until occurrence of one of the following events: cardiac death, non-fatal myocardial infarction, unstable angina requiring unplanned coronary revascularization, or ischemic stroke. Results: During the follow-up period, 59 patients had cardiovascular events. Multivariate Cox analysis revealed that high levels of RLP-C (>= 4.3 mg/dL; median value) were a significant risk factor for cardiovascular events, independent of traditional risk factors (HR: 1.30; 95% CI: 1.04-1.63; p = 0.02). The addition of high levels of RLP-C to traditional risk factors improved net reclassification improvement (NRI) and integrated discrimination improvement (IDI) (NRI 0.36, p = 0.01; and IDI 0.03, p = 0.02). Conclusions: RLP-C is useful for risk assessment of future cardiovascular events in patients having type 2 DM and CKD. (C) 2016 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据